News
Third-party developers can use the platform to build their own products or update instruments. 
        
        
          The scheme is being run in partnership with government technology firm PUBLIC.
        
        
          The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
        
        
          The two companies will also collaborate on a clinical study using AI mammography.
        
        
          This IPO comes roughly a year after the company closed a $25 million SPAC. 
        
        
          The company will cater to individuals with serious mental illness and severe depression. 
        
        
          Nanox also completed the acquisition of USARAD Holdings and its affiliated company, MDWEB.
        
        
          The plan, built with Trustmark Health Benefits, is centered on Teladoc’s primary care offering, recently made available to payers.
        
        
          HoneyNaps claims its software provides more accurate readings than conventional auto-scoring.
        
        
          Also: Pediatric sleep app Huckleberry raises $12.5 million, and illumigyn, maker of a platform for remote gynecological imaging, brings in $33 million.
        
        
           
 
 
 
 
 
 
 
 
